Stella Diagnostics (Stella Diagnostics) EV-to-FCF : (As of Jun. 05, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Stella Diagnostics's Enterprise Value is $26.27 Mil. Stella Diagnostics does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Stella Diagnostics's EV-to-FCF at this moment.

The historical rank and industry rank for Stella Diagnostics's EV-to-FCF or its related term are showing as below:

SLDX's EV-to-FCF is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 25.5
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), Stella Diagnostics's stock price is $0.0521. Stella Diagnostics does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Stella Diagnostics's PE Ratio at this moment.

Stella Diagnostics EV-to-FCF Historical Data

The historical data trend for Stella Diagnostics's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics EV-to-FCF Chart

Stella Diagnostics Annual Data

Trend

EV-to-FCF

Stella Diagnostics Quarterly Data
	Sep22	Sep23
EV-to-FCF	-	-

Competitive Comparison of Stella Diagnostics's EV-to-FCF

For the Diagnostics & Research subindustry, Stella Diagnostics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stella Diagnostics's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's EV-to-FCF falls into.

Stella Diagnostics EV-to-FCF Calculation

Stella Diagnostics's EV-to-FCF for today is calculated as:

EV-to-FCF	=	Enterprise Value (Today)	/	Free Cash Flow (TTM)
	=	26.273	/
	=

Stella Diagnostics (OTCPK:SLDX) EV-to-FCF Explanation

Stella Diagnostics's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.0521	/
	=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Stella Diagnostics EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » EV-to-FCF

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.